生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | VHL is an E3 ligase which has previously been targeted in numerous PROTACs with peptidic ligands. VHL is involved in related pathways including innate immune system and HIF-1 signaling pathway. VL285 is a potent VHL ligand with IC50 values of 0.34 μM. In vitro, treatment with 100 μM VL285 significantly reduced HaloPPOTAC3 mediated activity to 50% degradation[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.88mL 0.38mL 0.19mL |
9.39mL 1.88mL 0.94mL |
18.77mL 3.75mL 1.88mL |
参考文献 |
---|